Scientists discover a hidden immune weapon against deadly lung cancer
Researchers have identified a specific immune cell that can detect and destroy small cell lung cancer, a highly aggressive disease. This discovery suggests that existing medications could be repurposed to boost these cells, potentially improving the efficacy of immunotherapy for more patients.
Why it matters
Small cell lung cancer has a very low survival rate, and this discovery offers a promising new pathway for more effective, targeted cancer treatments.
Scientists have identified a previously overlooked type of immune cell that can detect and destroy small cell lung cancer, the most aggressive form of lung cancer worldwide.
The discovery, reported in the journal Cancer Cell by researchers at WEHI, revealed that patients with greater numbers of these specialized immune cells tended to survive longer. The findings point to a previously unrecognized immune defense that could provide a new way to attack tumors that are notoriously difficult to treat.
The research team also demonstrated that medications already in use could enhance the ability of these immune cells to kill cancer. This approach could eventually improve existing treatments and increase the number of patients who benefit from immunotherapy.
Why Small Cell Lung Cancer Is So Difficult to Treat
Small cell lung cancer (SCLC) is among the deadliest cancers, with fewer than 7% of patients surviving for five years after diagnosis.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in